UBE2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.343800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.832200E-01
Normal-vs-Stage2
9.161800E-01
Normal-vs-Stage3
7.915800E-01
Normal-vs-Stage4
8.170600E-01
Stage1-vs-Stage2
8.581200E-01
Stage1-vs-Stage3
7.723000E-01
Stage1-vs-Stage4
7.913600E-01
Stage2-vs-Stage3
5.807000E-01
Stage2-vs-Stage4
8.512200E-01
Stage3-vs-Stage4
6.518400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.506200E-01
Normal-vs-AfricanAmerican
8.839400E-01
Normal-vs-Asian
8.900000E-01
Caucasian-vs-AfricanAmerican
8.933000E-01
Caucasian-vs-Asian
7.880400E-01
AfricanAmerican-vs-Asian
9.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.705400E-01
Normal-vs-Female
8.780400E-01
Male-vs-Female
6.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.352000E-01
Normal-vs-Age(41-60Yrs)
3.622400E-01
Normal-vs-Age(61-80Yrs)
7.265200E-01
Normal-vs-Age(81-100Yrs)
5.974000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.146000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.319200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.050400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.03540000001767E-06
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.196600E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.464800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.456400E-01
Normal-vs-Daily Drinker
7.825400E-01
Normal-vs-Weekly Drinker
9.232600E-01
Normal-vs-Occasional Drinker
5.932400E-01
Normal-vs-Social Drinker
9.891800E-01
Non Drinker-vs-Daily Drinker
6.775000E-01
Non Drinker-vs-Weekly Drinker
9.635000E-01
Non Drinker-vs-Occasional Drinker
2.440600E-01
Non Drinker-vs-Social Drinker
8.782600E-01
Daily Drinker-vs-Weekly Drinker
7.550200E-01
Daily Drinker-vs-Occasional Drinker
1.291450E-01
Daily Drinker-vs-Social Drinker
5.403000E-01
Weekly Drinker-vs-Occasional Drinker
2.872800E-01
Weekly Drinker-vs-Social Drinker
8.585000E-01
Occasional Drinker-vs-Social Drinker
2.463400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.012600E-01
Normal-vs-Grade 2
7.748200E-01
Normal-vs-Grade 3
7.889200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.429620E-02
Grade 1-vs-Grade 3
3.615500E-02
Grade 1-vs-Grade 4
9.012600E-01
Grade 2-vs-Grade 3
7.195600E-01
Grade 2-vs-Grade 4
7.748200E-01
Grade 3-vs-Grade 4
7.889200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.376000E-01
Normal-vs-NonDiabetic
8.643800E-01
Diabetic-vs-NonDiabetic
5.516400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.398600E-01
Normal-vs-NoPancreatitis
9.878800E-01
Pancreatitis-vs-NoPancreatitis
1.263220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.951400E-01
Normal-vs-N1
8.945600E-01
N0-vs-N1
5.788000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.361400E-01
Normal-vs-TP53-NonMutant
6.636000E-01
TP53-Mutant-vs-TP53-NonMutant
4.842900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
